EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply

Position Paper – Unitary SPC & Unified Mechanism for the Granting of SPCs

Medicines for Europe Position Paper On Patent Linkage

Market Review – European Generic Medicine Markets 2020

Position Paper. Incentives Review The Orphan and Paediatric Incentives

Medicines for Europe Position Paper on Bolar Exemption – Feb 2021

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy